Chapter 45. Cutaneous Leishmaniasis

  1. Hywel Williams MSC, PhD, FRCP Professor Dermato-Epidemiology Co-ordinating Editor
  1. Urbà González MD, PhD Dermatologist Senior Consultant1 and
  2. Mayda Delma Villalta Alvarez Pediatrician2

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300161.ch45

Evidence-Based Dermatology, Second Edition

Evidence-Based Dermatology, Second Edition

How to Cite

González, U. and Delma Villalta Alvarez, M. (2008) Cutaneous Leishmaniasis, in Evidence-Based Dermatology, Second Edition (ed H. Williams), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300161.ch45

Editor Information

  1. Centre of Evidence-Based Dermatology, Nottingham University Hospital NHS Trust, Queen's Medical Centre, Nottingham, UK

Author Information

  1. 1

    Departmant of Dermatology, Clinica Plató, Barcelona, Spain

  2. 2

    Private Practice, San Salvador, El Salvador

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405145183

Online ISBN: 9781444300161



  • leishmaniasis – Leishmania caused infection diseases;
  • cutaneous leishmaniasis;
  • ulcerative cutaneous leishmaniasis;
  • intralesional zinc sulfate solution;
  • intravenous/intramuscular meglumine antimonate;
  • American cutaneous leishmaniasis and local treatments;
  • systemic therapy - first-line drugs in American cutaneous leishmaniasis;
  • intramuscular pentamidine;
  • intravenous/intramuscular stibogluconate


This chapter contains sections titled:

  • Background

  • Questions

  • Acknowledgments

  • References